Out of the TNF superfamily of death-inducing ligands, TRAIL was taken since it is described to selectively induce apoptosis in a large variety of cancer cells but not in normal cells (Ashkenazi et al, 1999; Walczak et al, 1999). This evidence concerns the gene TNF and cancer.